Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza.
Saved in:
| Title: | Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza. |
|---|---|
| Authors: | Chivukula S; Sanofi Pasteur, Cambridge, MA, USA. Sudha.Chivukula@sanofi.com., Plitnik T; Emergent Biosolutions, San Diego, CA, USA., Tibbitts T; Sanofi Pasteur, Cambridge, MA, USA., Karve S; Translate Bio, a Sanofi Company, Lexington, MA, USA., Dias A; Translate Bio, a Sanofi Company, Lexington, MA, USA., Zhang D; Sanofi Pasteur, Orlando, FL, USA., Goldman R; Translate Bio, a Sanofi Company, Lexington, MA, USA., Gopani H; Translate Bio, a Sanofi Company, Lexington, MA, USA., Khanmohammed A; Translate Bio, a Sanofi Company, Lexington, MA, USA., Sarode A; Translate Bio, a Sanofi Company, Lexington, MA, USA., Cooper D; Translate Bio, a Sanofi Company, Lexington, MA, USA., Yoon H; Sanofi Pasteur, Orlando, FL, USA., Kim Y; Sanofi Pasteur, Cambridge, MA, USA., Yan Y; Sanofi Pasteur, Cambridge, MA, USA., Mundle ST; Sanofi Pasteur, Cambridge, MA, USA., Groppo R; Pioneering Medicines, Cambridge, MA, USA., Beauvais A; Sanofi Pasteur, Cambridge, MA, USA., Zhang J; Seqirus Inc, Cambridge, MA, USA., Anosova NG; Sanofi Pasteur, Cambridge, MA, USA., Lai C; Sanofi Pasteur, Cambridge, MA, USA., Li L; Sanofi Pasteur, Cambridge, MA, USA., Ulinski G; Sanofi, Framingham, MA, USA., Piepenhagen P; Sanofi, Framingham, MA, USA., DiNapoli J; Sanofi Pasteur, Cambridge, MA, USA., Kalnin KV; Emergent Biosolutions, San Diego, CA, USA., Landolfi V; Sanofi Pasteur, Swiftwater, PA, USA., Swearingen R; Translate Bio, a Sanofi Company, Lexington, MA, USA., Fu TM; Texas Therapeutics Institute, The University of Texas Health Science Center at Houston, Houston, TX, USA., DeRosa F; Translate Bio, a Sanofi Company, Lexington, MA, USA., Casimiro D; Sanofi Pasteur, Marcy l'Étoile, France. |
| Source: | NPJ vaccines [NPJ Vaccines] 2021 Dec 16; Vol. 6 (1), pp. 153. Date of Electronic Publication: 2021 Dec 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34916519 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chivukula+S%22">Chivukula S</searchLink>; Sanofi Pasteur, Cambridge, MA, USA. Sudha.Chivukula@sanofi.com.<br /><searchLink fieldCode="AU" term="%22Plitnik+T%22">Plitnik T</searchLink>; Emergent Biosolutions, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tibbitts+T%22">Tibbitts T</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Karve+S%22">Karve S</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dias+A%22">Dias A</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+D%22">Zhang D</searchLink>; Sanofi Pasteur, Orlando, FL, USA.<br /><searchLink fieldCode="AU" term="%22Goldman+R%22">Goldman R</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Gopani+H%22">Gopani H</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Khanmohammed+A%22">Khanmohammed A</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sarode+A%22">Sarode A</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+D%22">Cooper D</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yoon+H%22">Yoon H</searchLink>; Sanofi Pasteur, Orlando, FL, USA.<br /><searchLink fieldCode="AU" term="%22Kim+Y%22">Kim Y</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Yan+Y%22">Yan Y</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Mundle+ST%22">Mundle ST</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Groppo+R%22">Groppo R</searchLink>; Pioneering Medicines, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Beauvais+A%22">Beauvais A</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Seqirus Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Anosova+NG%22">Anosova NG</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Lai+C%22">Lai C</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Li+L%22">Li L</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ulinski+G%22">Ulinski G</searchLink>; Sanofi, Framingham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Piepenhagen+P%22">Piepenhagen P</searchLink>; Sanofi, Framingham, MA, USA.<br /><searchLink fieldCode="AU" term="%22DiNapoli+J%22">DiNapoli J</searchLink>; Sanofi Pasteur, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kalnin+KV%22">Kalnin KV</searchLink>; Emergent Biosolutions, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Landolfi+V%22">Landolfi V</searchLink>; Sanofi Pasteur, Swiftwater, PA, USA.<br /><searchLink fieldCode="AU" term="%22Swearingen+R%22">Swearingen R</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Fu+TM%22">Fu TM</searchLink>; Texas Therapeutics Institute, The University of Texas Health Science Center at Houston, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22DeRosa+F%22">DeRosa F</searchLink>; Translate Bio, a Sanofi Company, Lexington, MA, USA.<br /><searchLink fieldCode="AU" term="%22Casimiro+D%22">Casimiro D</searchLink>; Sanofi Pasteur, Marcy l'Étoile, France. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2021 Dec 16; Vol. 6 (1), pp. 153. <i>Date of Electronic Publication: </i>2021 Dec 16. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34916519 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41541-021-00420-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 153 Titles: – TitleFull: Development of multivalent mRNA vaccine candidates for seasonal or pandemic influenza. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chivukula S – PersonEntity: Name: NameFull: Plitnik T – PersonEntity: Name: NameFull: Tibbitts T – PersonEntity: Name: NameFull: Karve S – PersonEntity: Name: NameFull: Dias A – PersonEntity: Name: NameFull: Zhang D – PersonEntity: Name: NameFull: Goldman R – PersonEntity: Name: NameFull: Gopani H – PersonEntity: Name: NameFull: Khanmohammed A – PersonEntity: Name: NameFull: Sarode A – PersonEntity: Name: NameFull: Cooper D – PersonEntity: Name: NameFull: Yoon H – PersonEntity: Name: NameFull: Kim Y – PersonEntity: Name: NameFull: Yan Y – PersonEntity: Name: NameFull: Mundle ST – PersonEntity: Name: NameFull: Groppo R – PersonEntity: Name: NameFull: Beauvais A – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Anosova NG – PersonEntity: Name: NameFull: Lai C – PersonEntity: Name: NameFull: Li L – PersonEntity: Name: NameFull: Ulinski G – PersonEntity: Name: NameFull: Piepenhagen P – PersonEntity: Name: NameFull: DiNapoli J – PersonEntity: Name: NameFull: Kalnin KV – PersonEntity: Name: NameFull: Landolfi V – PersonEntity: Name: NameFull: Swearingen R – PersonEntity: Name: NameFull: Fu TM – PersonEntity: Name: NameFull: DeRosa F – PersonEntity: Name: NameFull: Casimiro D IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 12 Text: 2021 Dec 16 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2059-0105 Numbering: – Type: volume Value: 6 – Type: issue Value: 1 Titles: – TitleFull: NPJ vaccines Type: main |
| ResultId | 1 |